Retatrutide 20 mg

Retatrutide 20 mg

$82.90

Triple receptor agonist · GLP-1 / GIP / Glucagon · 20 mg

Specification: 20 mg / vial

Availability: Usually ships within 2 days.

Lab certificates

Retatrutide 20 mg u2014 ERP batchJanoshik · Ref. 81056View COA →
SKU: RET20 Category:
Research product information

Retatrutide 20 mg

Structured product, pathway, quality-documentation, and laboratory-handling information.

Product overview

Product
Retatrutide 20 mg
SKU
RET20
Compound
Retatrutide
Strength
20 mg / vial
Product format
Lyophilised peptide
Quantity per vial
20 mg
Category
Stock
Availability shown at checkout

Compound profile

Receptor or pathway
GLP-1 / GIP / glucagon receptor agonism
Common areas of scientific investigation
  • Metabolic pathway studies
  • Incretin and glucagon signalling studies
  • Body-composition and appetite investigation
Known status
Investigational compound studied in clinical study settings.
Important limitations of available evidence
Published evidence is still developing and may vary by trial design and population.

Quality documentation

Certificate reference
81056
Tested purity
See certificate
Testing method
See certificate
Testing laboratory
Janoshik
Test date
See certificate
Open certificate →

Storage and laboratory handling

Unopened storage
Follow supplier and batch-label storage instructions before opening.
Light exposure
Protect from direct light exposure.
Temperature range
Use storage conditions listed on batch label and documentation.
Lyophilised
Yes
  • Use calibrated laboratory tools and sterile technique.
  • Record handling and storage conditions for reproducibility.

Recommended laboratory accessories

Description

Retatrutide 20 mg — extended research vial. Triple agonist targeting GLP-1, GIP, and glucagon receptors for metabolic research.

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 20 mg”

Your email address will not be published. Required fields are marked *

Related products